Cargando…

An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease

AIM: To characterize progression of Alzheimer's disease (AD) using proton magnetic resonance spectroscopy ((1)H MRS). METHODS: Eleven subjects with mild to moderate AD underwent neurocognitive testing and single-voxel (1)H MRS from the precuneus and posterior cingulate region at baseline, after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordon, Marc L., Kingsley, Peter B., Goldberg, Terry E., Koppel, Jeremy, Christen, Erica, Keehlisen, Lynda, Kohn, Nina, Davies, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2012
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435529/ https://www.ncbi.nlm.nih.gov/pubmed/22962555 http://dx.doi.org/10.1159/000341604

Ejemplares similares

Study of the Neuroprotective Effects of Memantine in Patients with Mild to Moderate Ischemic Stroke
por: Kafi, Hamidreza, et al.
Publicado: (2014)

Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine
por: Schmidt, R, et al.
Publicado: (2008)

Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
por: Tampi, Rajesh R, et al.
Publicado: (2007)

Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study
por: Koppel, Jeremy, et al.
Publicado: (2009)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer’s disease in the Netherlands
por: Hoogveldt, Bart, et al.
Publicado: (2011)

Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease
por: Peters, Oliver, et al.
Publicado: (2015)

Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)
por: Knapp, Martin, et al.
Publicado: (2016)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT
por: Jones, Rob, et al.
Publicado: (2009)

Proton MR spectroscopy in mild traumatic brain injury
por: Kubas, Bożena, et al.
Publicado: (2010)

Pharmacodynamics of Memantine: An Update
por: Rammes, G, et al.
Publicado: (2008)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
por: Puangthong, Umamon, et al.
Publicado: (2009)

Memantine for the patients with mild cognitive impairment in Parkinson’s disease: a pharmacological fMRI study
por: Kawashima, Shoji, et al.
Publicado: (2022)

Memantine for the Treatment of Behavioral Disturbance in Unspecified Major Neurocognitive Disorder
por: Terry, Peyton H, et al.
Publicado: (2021)

Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer's Disease: A Review of Clinical Trials
por: Molino, Ivana, et al.
Publicado: (2013)

Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
por: Rive, Benoît, et al.
Publicado: (2013)

Effect of memantine combined with citalopram on cognition of BPSD and moderate Alzheimer's disease: A clinical trial
por: Zhou, Tiantian, et al.
Publicado: (2019)

The effects of memantine on prepulse inhibition
por: Swerdlow, NR, et al.
Publicado: (2009)

Pharmacokinetics of memantine in rats and mice
por: Beconi, Maria G., et al.
Publicado: (2012)

Memantine Ameliorates Migraine Headache
por: Shanmugam, Sundar, et al.
Publicado: (2019)

Memantine Protects From Exacerbation of Ischemic Stroke and Blood Brain Barrier Disruption in Mild But Not Severe Hyperhomocysteinemia
por: Gu, Sean X., et al.
Publicado: (2020)

An open-label trial of memantine in treatment-resistant obsessive-compulsive disorder
por: Bakhla, Ajay Kumar, et al.
Publicado: (2013)

A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease
por: Deardorff, William James, et al.
Publicado: (2016)

Combined application of tenuigenin and β-asarone improved the efficacy of memantine in treating moderate-to-severe Alzheimer’s disease
por: Chang, Wenguang, et al.
Publicado: (2018)

Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer’s Disease, In Silico Trials
por: Świetlik, Dariusz, et al.
Publicado: (2022)

Impact of Meditation–Based Lifestyle Modification on HRV in Outpatients With Mild to Moderate Depression: An Exploratory Study
por: Bringmann, Holger C., et al.
Publicado: (2022)

Update on the use of memantine in Alzheimer’s disease
por: van Marum, Robert J
Publicado: (2009)

Memantine as an Augmentation Therapy for Anxiety Disorders
por: Schwartz, Thomas L., et al.
Publicado: (2012)

Tackling Negative Symptoms of Schizophrenia with Memantine
por: Paraschakis, Antonios
Publicado: (2014)

Efficacy of Memantine Hydrochloride in Neuropathic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019)

Memantine in neurological disorders – schizophrenia and depression
por: Czarnecka, Kamila, et al.
Publicado: (2021)

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022)

An Open-Label Trial of Memantine for Cognitive Impairment in Patients with Posttraumatic Stress Disorder
por: Ramaswamy, Sriram, et al.
Publicado: (2015)

The efficacy of memantine in the treatment of civilian posttraumatic stress disorder: an open-label trial
por: Hori, Hiroaki, et al.
Publicado: (2021)

Relationship Between MR Spectroscopy-Detected Glutamatergic Neurometabolites and Changes in Social Behaviors in a Pilot Open-Label Trial of Memantine for Adults With Autism Spectrum Disorder
por: Nair, Neetu, et al.
Publicado: (2022)

Is memantine a potential therapeutic for Rett syndrome?
por: Bello, Olivia, et al.
Publicado: (2013)

Memantine and Kynurenic Acid: Current Neuropharmacological Aspects
por: Majláth, Zsófia, et al.
Publicado: (2016)

Crystal structure of memantine–carboxyborane
por: Ayudhya, Theppawut I., et al.
Publicado: (2019)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
por: Marotta, Giambattista, et al.
Publicado: (2020)

Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
por: Chow, Tiffany W, et al.
Publicado: (2011)

An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough
por: Abdulqawi, Rayid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qrapq3mkrqfe533qa7eo0evkqk